Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The closing price of Accendra Health Inc (NYSE: ACH) was $2.2 for the day, down -12.70% from the previous closing price of $2.52. In other words, the price has decreased by -$12.70 from its previous closing price. On the day, 1.51 million shares were traded. ACH stock price reached its highest trading level at $2.45 during the session, while it also had its lowest trading level at $2.2.
Ratios:
Our analysis of ACH’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.84 and its Current Ratio is at 0.86.
On July 19, 2024, Citigroup Upgraded its rating to Buy which previously was Neutral and also lowered its target price recommendation from $24 to $19. On February 26, 2024, Leerink Partners started tracking the stock assigning a Market Perform rating and target price of $24.Leerink Partners initiated its Market Perform rating on February 26, 2024, with a $24 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 12 ’25 when Coliseum Capital Management, L bought 720,000 shares for $5.15 per share. The transaction valued at 3,708,000 led to the insider holds 12,282,955 shares of the business.
Coliseum Capital Management, L bought 492,852 shares of ACH for $2,617,044 on Aug 14 ’25. The 10% Owner now owns 13,100,807 shares after completing the transaction at $5.31 per share. On Aug 13 ’25, another insider, Coliseum Capital Management, L, who serves as the 10% Owner of the company, bought 325,000 shares for $5.46 each. As a result, the insider paid 1,774,500 and bolstered with 12,607,955 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACH now has a Market Capitalization of 170162512 and an Enterprise Value of 2379969536. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.03. Its current Enterprise Value per Revenue stands at 0.221 whereas that against EBITDA is 4.698.
Stock Price History:
The Beta on a monthly basis for ACH is 1.37, which has changed by -0.830303 over the last 52 weeks, in comparison to a change of 0.14025438 over the same period for the S&P500. Over the past 52 weeks, ACH has reached a high of $15.54, while it has fallen to a 52-week low of $1.84. The 50-Day Moving Average of the stock is -18.45%, while the 200-Day Moving Average is calculated to be -60.10%.
Shares Statistics:
ACH traded an average of 1.99M shares per day over the past three months and 2170260 shares per day over the past ten days. A total of 77.30M shares are outstanding, with a floating share count of 74.42M. Insiders hold about 3.78% of the company’s shares, while institutions hold 101.41% stake in the company. Shares short for ACH as of 1767139200 were 9021735 with a Short Ratio of 5.04, compared to 1764288000 on 10038119. Therefore, it implies a Short% of Shares Outstanding of 9021735 and a Short% of Float of 20.889999.
Earnings Estimates
. The current rating of Accendra Health Inc (ACH) reflects the combined expertise of 6.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is $0.14, with high estimates of $0.16 and low estimates of $0.12.
Analysts are recommending an EPS of between $1.06 and $0.95 for the fiscal current year, implying an average EPS of $1.01. EPS for the following year is $0.94, with 6.0 analysts recommending between $1.0 and $0.82.
Revenue Estimates
It is expected that $90B in revenue will be generated in. The current quarter, according to 6 analysts. It ranges from a high estimate of $721M to a low estimate of $702M. The current estimate, Accendra Health Inc’s year-ago sales were $2.7BFor the next quarter, 6 analysts are estimating revenue of $647.55M. There is a high estimate of $661.9M for the next quarter, whereas the lowest estimate is $625M.
A total of 6 analysts have provided revenue estimates for ACH’s current fiscal year. The highest revenue estimate was $4.73B, while the lowest revenue estimate was $2.75B, resulting in an average revenue estimate of $3.09B. In the same quarter a year ago, actual revenue was $10.7BBased on 6 analysts’ estimates, the company’s revenue will be $2.6B in the next fiscal year. The high estimate is $2.7B and the low estimate is $2.53B.
